GLP-1 AGONISTS IN THE TREATMENT OF CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES AND OBESITY

Descargar Publicación
Obesity-Related Inflammatory Biomarkers in the Elderly Population Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis